Guidelines for Parental Involvement in the Care of Suicidal Youth

NCT ID: NCT05296343

Last Updated: 2024-11-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

61 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-05-18

Study Completion Date

2024-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Parents occupy a central place in the emergency care of suicidal adolescents and young adults. However, from 15 to 25yo, three different administrative situations exist in France:

* \<16yo: admission to a child ED by a team trained to receive the youngest patients.
* 16-18yo: admission to an adult ED by team devoted to adult care, no exit without parents' authorization.
* \>18yo: admission to an adult ED by team.

Laying on qualitative observational protocol and a Delphi approach, this study will explore the perspective of adolescents and young adults following a suicidal attempt, the perspective of their parents, and the perspective of their healthcare professionals to build guidelines for parental involvement in care of suicidal youths.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Suicide is the second leading cause of death among 15-25 year olds, with the highest rate of hospitalization for SC of any age group. The psychopathology of suicidal behavior in adolescents and young adults (AYA) is homogeneous: risk factors, precipitating factors, representations. Parents occupy a central place in care. They are i) involved in the care decision; ii) actively involved in care; and ii) a source of motivation for trust and adherence to care.

However, if the psychopathology of suicidal crisis is homogeneous, the transition between pediatric and adult care implies very different management in the emergency department (ED). In France, three situations can be described:

* \<16yo: admission to a child ED by a team trained to receive the youngest patients.
* 16-18yo: admission to an adult ED by team devoted to adult care, no exit without parents' authorization.
* \>18yo: admission to an adult ED by team devoted to adult care, no right to contact the parents in case of patient opposition.
* Before 16 years of age: admission to the children's UAS, care by a team trained to receive the youngest patients.
* 16-18 years: admission to the adult UAS, care by adult professionals, clinical and legal particularities of care for minors.
* After 18 years old: admission to adult UAS, legal constraints of the adult care setting.

The objectives of this qualitative observational study is to build guidelines for the involvement of the parents in the care in these three situations.

The study will include adolescents and young adults from the three situations, their parents and the professionals who take care of them. Individual semi-structured interviews will be organized to collect their experiences. Qualitative analyses will be conduct, following Interpretative Phenomenological Analysis. A pre-approved guideline will be construct and a Delphi approach will be conducted to approved the final version of the guideline.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Suicide, Attempted Emergencies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adolescents and young adults

Boys and girls from 15 to 25 years old admitted to an Emergency Department (ED) following a suicidal act or considered as such by the medical team

No interventions assigned to this group

Parents

One or the two parents of the included adolescents and young adults

No interventions assigned to this group

Healthcare professionals

Professionals working in one emergency departments of the inclusion centers and who usually take care of suicidal adolescents and young adults

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Adolescents and Young adults

* Admitted to an Emergency Department (ED) following a suicidal act or considered as such by the medical team

Parents

* Parents of the included youths \>18y

Healthcare professionals

* \>18y
* Working in ED
* Usually taking care of suicidal youths

All the participants

* French speaking
* Affiliation to a social security regime
* Participation agreement

Exclusion Criteria

All the participants

* Present an acute somatic or psychiatric disease which may hinder the well organization of the interview
Minimum Eligible Age

15 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Clermont-Ferrand

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jonathan Lachal

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Clermont-Ferrand

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Clermont-Ferrand

Clermont-Ferrand, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A03244-37

Identifier Type: OTHER

Identifier Source: secondary_id

AOI 2021 LACHAL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.